{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:21Z","timestamp":1786123341085,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1213\/ane.0b013e31822dd4ca","type":"journal-article","created":{"date-parts":[[2011,10,22]],"date-time":"2011-10-22T02:30:37Z","timestamp":1319250637000},"page":"975-976","source":"Crossref","is-referenced-by-count":1,"title":["Mining for Mutations in Malignant Hyperthermia"],"prefix":"10.1213","volume":"113","author":[{"given":"Henry","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210902","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1213\/ANE.0b013e318222af2e","article-title":"Future directions in malignant hyperthermia research and patient care.","volume":"113","author":"Dirksen","year":"2011","journal-title":"Anesth Analg"},{"key":"R2-5-20210902","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/ALN.0b013e318190bb08","article-title":"Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005.","volume":"110","author":"Rosero","year":"2009","journal-title":"Anesthesiology"},{"key":"R3-5-20210902","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","article-title":"Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.","volume":"343","author":"MacLennan","year":"1990","journal-title":"Nature"},{"key":"R4-5-20210902","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1213\/ANE.0b013e318228293e","article-title":"Screening of the ryanodine 1 gene for malignant hyperthermia causative mutations by high tesolution melt curve analysis.","volume":"113","author":"Broman","year":"2011","journal-title":"Anesth Analg"},{"key":"R5-5-20210902","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","article-title":"Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population.","volume":"102","author":"Sambuughin","year":"2005","journal-title":"Anesthesiology"},{"key":"R6-5-20210902","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.22119","article-title":"RYR1 mutations are a common cause of congenital myopathies with central nuclei.","volume":"68","author":"Wilmshurst","year":"2010","journal-title":"Ann Neurol"},{"key":"R7-5-20210902","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/ALN.0b013e3181c29504","article-title":"Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms.","volume":"112","author":"Capacchione","year":"2010","journal-title":"Anesthesiology"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e31822dd4ca","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:17:33Z","timestamp":1786112253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201111000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e31822dd4ca","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}